Obstetrics – Medxy AI

High Versus Low Transvaginal Cerclage for Preventing Preterm Birth: Insights from the C-STICH Trial Secondary Analysis

By MedXY 08/22/2026

This secondary analysis of the C-STICH trial compares pregnancy outcomes following high versus low vaginal cerclage in women at high risk of preterm birth, finding no significant difference in pregnancy loss but a modest benefit of high cerclage in prolonging gestation and reducing very early preterm births.

Infectious Diseases news OB/GYN & Women’s Health

Hantavirus in Pregnancy: Why Obstetricians Need a High Index of Suspicion

By MedXY 06/17/2026

Hantavirus infection in pregnancy is rare but potentially fatal. Obstetricians should suspect it after rodent or travel exposure, recognize rapid respiratory decline, and prioritize supportive critical care because no proven antiviral therapy exists.

AI news OB/GYN & Women’s Health

Phenotyping Preeclampsia Using Unsupervised Machine Learning: A Prospective Cohort Study

By MedXY 06/06/2026

Unsupervised machine learning identified three distinct preeclampsia phenotypes linked to timing of delivery, placental dysfunction, fetal growth, and complications, suggesting a path toward more personalized risk assessment and management.

news OB/GYN & Women’s Health Psychiatry

Association Between Delivery Mode and Postpartum Psychiatric Conditions

By MedXY 05/28/2026

A large U.S. cohort study found higher rates of postpartum psychiatric conditions after planned or unplanned cesarean delivery, but not after successful operative vaginal delivery, highlighting the need for closer postpartum mental health follow-up.

news OB/GYN & Women’s Health Public Health

Association Between Racial Segregation of Labor and Delivery Services and Use of Trial of Labor and Vaginal Birth After Cesarean

By MedXY 05/20/2026

Hospitals that serve more Black patients had higher rates of trial of labor after cesarean and VBAC success among low-risk patients, suggesting hospital practices may influence cesarean-related disparities.

news OB/GYN & Women’s Health

Six Hours May Be Enough for Intrauterine Balloon Tamponade After Postpartum Hemorrhage

By MedXY 05/13/2026

A randomized trial found that 6 hours of intrauterine balloon tamponade was noninferior to 18 hours for controlling postpartum hemorrhage after vaginal delivery, suggesting earlier removal may be reasonable in stable patients.

news

A New Dutch Prediction Model Identifies Nulliparous Women at Higher Risk of Obstetric Anal Sphincter Injury

By MedXY 04/20/2026

A Dutch nationwide study developed and temporally validated two OASI risk models for nulliparous women, with moderate discrimination but excellent calibration. The models may help target counseling and preventive obstetric strategies.

Clinical Updates news OB/GYN & Women's Health

The Rising Burden of Anemia in Pregnancy: Epidemiological Trends, Clinical Impact, and Evolving Management Strategies

By MedXY 04/02/2026

This review synthesizes recent evidence on pregnancy-related anemia, highlighting a 25.6% US prevalence, the clinical significance of iron deficiency without anemia (IDWA), and the critical impact on maternal-fetal outcomes and cardiovascular health.

news

Clinical Trajectory of Early-Onset Severe Fetal Growth Restriction: Insights into Umbilical Artery Doppler Progression and Management

By MedXY 03/30/2026

This report examines the progression of Umbilical Artery Doppler abnormalities in 241 severe early-onset FGR cases, providing critical timelines for clinical deterioration, delivery planning, and fetal death risk assessment.

Clinical Updates news OB/GYN & Women's Health

Optimizing Iron Deficiency Management in Pregnancy: A Synthesis of Evidence for Intravenous Ferumoxytol vs. Oral Ferrous Sulfate

By MedXY 03/20/2026

This clinical review evaluates the superior efficacy of intravenous ferumoxytol over oral iron for treating gestational anemia, analyzing hematologic recovery and maternal outcomes based on the latest RCT evidence.

news

Mapping the Countdown: Umbilical Artery Doppler Deterioration and Mortality Risk in Severe Early-Onset Fetal Growth Restriction

By MedXY 03/18/2026

This study quantifies the rapid progression of Doppler abnormalities in severe early-onset FGR, providing critical timelines for corticosteroid administration and delivery planning to mitigate fetal death risks in high-risk pregnancies.

news OB/GYN & Women's Health

Scheduled Early-Term Birth: A Proven Strategy to Prevent Pre-eclampsia in High-Risk Pregnancies

By MedXY 01/08/2026

The PREVENT-PE trial demonstrates that risk-stratified scheduled birth at 37–38 weeks reduces pre-eclampsia incidence by 30% without increasing neonatal morbidity or emergency cesarean sections, offering a new standard for late-pregnancy management.